Medical
-
Erasmus Medical Center selects Agilent solutions
Agilent Technologies announced that Erasmus Medical Center, Rotterdam, Netherlands, has selected the Agilent SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part of the Erasmus Rucphen Family study to identify genetic risk factors for some complex genetic disorders.
Medical | 23 April 2012
-
JSR expands biomedical business
JSR Corporation and BIA Separations announced that they have entered a partnership which includes a minor equity position by JSR.
Medical | 29 February 2012
-
Life Technologies appoints president of medical sciences
Life Technologies announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as president, medical sciences.
Medical | 10 February 2012
-
ICON Acquires BeijingWits Medical Consulting
ICON has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting, a leading CRO in China. The transaction is expected to close in the first quarter of 2012.
Medical | 11 January 2012
-
ICON Medical Imaging is rated as top provider in imaging industry survey
ICON announced that its medical imaging division was rated as the top provider of imaging services according to an industry survey conducted by Blue Pyramid Consulting, an affiliate of the Avoca Group.
Medical | 05 January 2012
-
New data presented on phase 3 trial Of ELIQUIS (apixaban) in the prevention of venous thromboembolism in patients with acute medical illness
Bristol-Myers Squibb and Pfizer announced the results of the Phase 3 ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial, which evaluated apixaban versus enoxaparin in acutely ill medical patients, did not meet the primary efficacy outcome of superiority to enoxaparin for the endpoint of venous thromboembolism (VTE) and VTE-related death at day 30.
Medical | 15 November 2011
-
Pharmaceutical and biotech companies boost resources in medical affairs affiliates
Cutting Edge Information finds country-level medical affairs budgets now average $1.9 million.
Medical | 18 October 2011
-
Bristol-Myers Squibb and Saladax Biomedical expand collaboration for diagnostic assays for Alzheimer’s disease
Companies will collaborate globally on the development and regulatory approvals for certain diagnostic assays.
Medical | 20 September 2011
-
IE Singapore launches Biomedical R&D Consortium
Observing the trend of growing outsourced biomedical research & development (R&D) market in Asia, International Enterprise (IE) Singapore launched a new "Singapore Biomedical R&D consortium" to help Singapore-based companies tap into this potential. …
Medical | 01 July 2011
-
IE Singapore launches Biomedical R&D Consortium
Observing the trend of growing outsourced biomedical research & development (R&D) market in Asia, International Enterprise (IE) Singapore launched a new “Singapore Biomedical R&D consortium†to help Singapore-based companies tap into this potenti…
Medical | 23 June 2011
